Your session is about to expire
← Back to Search
Survivorship Care Interventions for Cancer
N/A
Waitlist Available
Led By Debra Friedman, MD
Research Sponsored by Debra Friedman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Cancer patient at least 18 years of age at time of cancer therapy
Completed cancer therapy within the previous 12 months (i.e., 12 months prior to consenting) and in complete remission
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 year
Awards & highlights
Study Summary
This trial will test a new way to provide survivorship care planning at three rural sites. The data from this trial will be used to plan a larger study to assess the effectiveness of this approach.
Who is the study for?
This trial is for English-speaking adults who finished cancer treatment within the last year, aimed at curing Stage 0 - III cancer, and are now in complete remission. They must be able to give informed consent.Check my eligibility
What is being tested?
The study tests a new approach to post-cancer care in rural areas using two methods: Survivorship Patient Navigation Intervention and Telehealth Survivorship Visit Intervention. It's a pilot study meant to guide future larger studies.See study design
What are the potential side effects?
Since this trial focuses on survivorship interventions rather than medications, traditional side effects like those seen with drugs may not apply. However, participants might experience emotional or psychological impacts.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years or older and have cancer.
Select...
I finished my cancer treatment in the last year and am now cancer-free.
Select...
I was treated for early-stage cancer with the goal of curing it.
Select...
I speak English and can give informed consent.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Estimate the barriers to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Estimate the facilitators to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Measure effectiveness of Telehealth on survivorship care
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Survivorship careExperimental Treatment2 Interventions
Participants in rural areas will receive a telehealth (providing health-related services through electronic communication technologies) survivorship care plan in combination with assistance from a patient navigator.
Find a Location
Who is running the clinical trial?
Debra FriedmanLead Sponsor
1 Previous Clinical Trials
700 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,120 Total Patients Enrolled
Debra Friedman, MD5.01 ReviewsPrincipal Investigator - Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
3 Previous Clinical Trials
1,628 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years or older and have cancer.I finished my cancer treatment in the last year and am now cancer-free.I was treated for early-stage cancer with the goal of curing it.I speak English and can give informed consent.
Research Study Groups:
This trial has the following groups:- Group 1: Survivorship care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the scope of enrollment for this research project?
"Affirmative. Clinical trials.gov's data illustrates that this clinical trial, first posted on February 26th 2021 is presently recruiting participants. Approximately 40 patients must be sourced from 3 distinct medical facilities."
Answered by AI
Is the recruitment of participants for this experiment still open?
"Per the details hosted on clinicaltrials.gov, this trial is currently accepting participants. This experiment was first advertised on February 26th 2021 and its specifications were recently modified on July 18th 2022."
Answered by AI
Share this study with friends
Copy Link
Messenger